Susunod

Auto-play

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 Mga view • 07/17/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play